KYORIN Pharmaceutical Co., Ltd. (KYRNF)
10.31
0.00 (0.00%)
USD |
OTCM |
May 14, 16:00
KYORIN Pharmaceutical Shareholders Equity (Quarterly) : 895.25M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 48.86B |
| Daiichi Sankyo Co., Ltd. | 10.46B |
| Eisai Co., Ltd. | 5.676B |
| Chugai Pharmaceutical Co., Ltd. | 11.99B |
| Santen Pharmaceutical Co., Ltd. | 1.867B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.229B |
| Total Liabilities (Quarterly) | 333.30M |
| Debt to Equity Ratio | 0.167 |
| Current Ratio | 4.602 |
| Net Debt Paydown Yield | 1.95% |